Trial Profile

Investigating the Inotropic Potential of Apelin in Healthy Volunteers and Patients With Chronic Stable Heart Failure.

Status: Completed

Phase of Trial: Phase II

Latest Information Update: 18 Sep 2021

Price :

$35 ^*

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

Drugs Apelin (Primary)
Indications Chronic heart failure
Focus Therapeutic Use
Acronyms INO-apelin

Most Recent Events

17 Apr 2012 Status changed from recruiting to completed as reported by United Kingdom Clinical Research Network record.
07 Apr 2012 Planned end date changed from 1 Aug 2013 to 1 Jun 2013 as reported by United Kingdom Clinical Research Network record.
18 Mar 2011 Additional lead trial centres (British Heart Foundation, National Health Service Lothian) and investigator (David Newby) identified as reported by UKCRN.

You need to be a logged in or subscribed to view this content

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial (opens in a new window)

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com